01 / BIOLOGY
Precision Biology
Comprehensive characterization of the individual — transcriptomics, microbiome, metabolomics, proteomics, biomarkers, imaging, wearables, lifestyle, and environmental exposure.
Albion Analytics integrates physiology, immunometabolism, artificial intelligence, and clinical expertise to measure a question conventional diagnostics often miss: how much adaptive biological reserve remains?
Each dimension characterizes the individual more completely. Together they form an explainable path from data to decision — and they meet at the model.
Comprehensive characterization of the individual — transcriptomics, microbiome, metabolomics, proteomics, biomarkers, imaging, wearables, lifestyle, and environmental exposure.
Integration of AI, statistical modelling, mechanistic pathway analysis, longitudinal trajectories, literature evidence, and physician knowledge into explainable clinical intelligence.
Physician-led interpretation producing individualized prevention, therapeutic decisions, functional strategies, lifestyle optimization, monitoring, and structured reassessment.
Three commitments hold across every module and every decision.
Every recommendation is transparent, interpretable, and clinically justifiable. No black-box medicine.
Health is a dynamic process. Decisions follow trajectories over time, not isolated measurements.
Intelligence supports clinical reasoning. The physician remains responsible for every final decision.
PM³ treats health as a balance: the metabolic demand placed on a system against its capacity to execute and its reserve to adapt. The margin is the buffer between them — and disease is what happens when it closes.
Rather than ranking single genes by p-value, PM³ reads coordinated shifts across biochemically linked pathways, annotating each gene by cofactor dependency, transport requirement, and subcellular compartment. Its central objective is to identify when inflammation creates a functional intracellular micronutrient deficit: nutrients may be present in circulation, yet become biologically inaccessible because cellular acquisition, activation, or utilization can no longer match demand.
◆ PEER-REVIEWED · METABOLITES 2025, 15, 399 Dervishi, A. A Systems Hypothesis of Lipopolysaccharide-Induced Vitamin Transport Suppression and Metabolic Reprogramming in Autism Spectrum Disorders. ↗ ◆ PEER-REVIEWED · METABOLITES 2026, 16, 416 Dervishi, A. Immunometabolic Stratification of Autism Spectrum Disorder by CD4⁺ T-Cell Phenotype Reveals Subtype-Specific Energetic Deficit and Coordinated Suppression of Micronutrient Acquisition Pathways. ↗Gene expression profiles reveal pathway activity and regulation.
Microbial diversity and function shape immunity, metabolism, barrier integrity.
Energy, substrates, and biosynthetic requirements driving cellular and systemic function.
Mitochondrial function, detoxification, enzyme capacity, transport, cellular machinery.
Functional reserve and resilience to stressors and challenges.
Health, homeostasis, and optimal physiological function.
PM³ introduces a critical precision-medicine distinction: systemic availability is not the same as intracellular access. During sustained inflammatory activation, metabolic demand may rise faster than execution capacity. ATP-intensive nutrient transport, receptor-mediated uptake, intracellular activation, and cofactor delivery can then become constrained—even when circulating concentrations appear adequate.
Conventional testing asks whether a nutrient is present in blood. PM³ asks whether the relevant cell can acquire it, activate it, deliver it to the correct compartment, and use it at the level demanded by its current immune-metabolic state.
Maps integrated immunometabolic demand—the biological load the system is attempting to execute.
Measures mismatch between induction demand and energetic execution capacity. Negative values indicate hidden deficit.
Precision medicine begins when we distinguish nutrient presence from nutrient usability.
Nine stages from molecular perturbation to failure. The framework's value lies in where along this cascade you are able to read the system.
The body's ability to maintain balance and withstand stress.
High reserve = flexibility and robust recovery. Low reserve = vulnerability.
Environmental, infectious, toxic, nutritional, or psychological stressors disrupt molecular balance.
Triggers can be acute (infection, toxin) or chronic (stress, diet, dysbiosis, pollutants).
Genes respond — some upregulated, some downregulated. Pathways are reprogrammed.
The earliest detectable molecular changes — the opportunity for early intervention.
Shifts in energy production, substrate utilization, redox balance, and biosynthetic pathways.
Cells adapt to the new reality — often at the cost of long-term efficiency and health.
Measurable changes in RNAs, proteins, metabolites, lipids, cytokines, and microbial metabolites.
Objective evidence of biological change — before symptoms appear.
Altered physiology in organs and systems — inflammation, autonomic dysfunction, metabolic dysregulation.
Systems begin to show measurable dysfunction, detectable with functional testing.
Fatigue, pain, cognitive dysfunction, GI issues, sleep disturbance, mood changes.
The patient feels it. Quality of life declines. This is the clinical threshold.
Chronic dysfunction and structural changes establish clinical disease entities.
Structural and functional damage becomes evident. Standard diagnostics usually detect it here.
The end stage of an unaddressed or overwhelmed system.
Organ failure, loss of resilience, severe illness, or death.
Five stages pass between the first readable signal
and the moment conventional medicine responds.
The transcriptomic response at stage 3 is measurable. Clinical disease at stage 8 is where standard diagnostics usually make the call. Everything in between — metabolic reprogramming, biomarker shift, physiological change, symptoms — is signal that is already there to be read. PM³ exists to close that gap.
By integrating transcriptomics, microbiome, metabolic demand, execution capacity, and adaptive reserve, progression becomes something you can see coming — and act on.
Across perioperative physiology, immunometabolism, and intensive-care stewardship, the same principle recurs: biological meaning emerges from relationships, trajectories, and reserve—not from isolated measurements.
Medicine should not merely detect disease. It should measure the biological capacity to remain healthy.
PM³ operationalizes this idea by mapping demand, execution capacity, adaptation, and loss of reserve.
Intraoperative hemodynamics demonstrate that cardiac output, oxygen delivery, pharmacologic suppression, and metabolic demand must be interpreted as a coupled state rather than as independent values.
PHYSIOLOGICAL SIGNAL → ADAPTIVE RESERVE → CLINICAL STATE View Scientific Reports paper →The published ASD study identified six CD4⁺-defined immunometabolic states and showed that pathway induction can exceed execution capacity. Negative Global Gap states were linked to coordinated suppression of ATP-intensive micronutrient acquisition pathways.
METABOLIC DEMAND − EXECUTION CAPACITY = HIDDEN ENERGETIC DEFICIT View Metabolites paper →Continuous vital signs, electrolyte and acid–base trajectories, and machine-learning models are used to estimate physiological instability across minutes, hours, and days. Fuzzy health indices translate complex signals into interpretable risk states, while dynamic ICU models adjust risk as the patient's condition evolves.
CONTINUOUS SIGNALS → DYNAMIC RISK STATE → EARLY CLINICAL ACTION View fuzzy ICU risk paper → View deep-learning ICU paper →Each domain applies the same architecture: measure dynamic state, quantify biological margin, preserve interpretability, and support—not replace—clinical reasoning.
Wearable health indices, continuous physiological monitoring, laboratory trajectories, and real-time risk adjustment for early recognition of deterioration and explainable ICU decision support.
Immunometabolic signatures and systems-level analysis of neurodevelopmental biology.
Metabolic and functional-medicine strategies grounded in mechanistic pathway analysis.
Preventive and longevity medicine built on longitudinal trajectory modelling.
The transparent modelling engine — interpretable pipelines over black-box prediction.
Datasets, publications, and reproducible methods anchoring the model in evidence.
Albion Analytics is a physician-led research practice in anaesthesiology and intensive care medicine. For collaboration, research, or questions, reach out directly.